Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival. [electronic resource]
Producer: 20140729Description: 1677-85 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Doxorubicin -- therapeutic use
- Female
- Genes, bcl-2
- Humans
- Induction Chemotherapy
- Lymphoma, Non-Hodgkin -- chemistry
- Male
- Middle Aged
- Positron-Emission Tomography
- Prednisone -- therapeutic use
- Proto-Oncogene Proteins c-myc -- analysis
- Rituximab
- Tomography, X-Ray Computed
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.